23andMe Holding Co Class A ME
Find similar stocks with Morningstar Investor.
Morningstar analysts do not currently cover ME, but with our powerful screener, you can find stocks in the same sector, industry, or style and filter on our unbiased ratings and valuation metrics.
News
-
PRIVACY ALERT: Genetic Testing Company 23andMe Faces Class Action Investigation for Cyberattack Potentially Impacting Five Million Customers
-
23andMe Reports Second Quarter Fiscal 2024 Financial Results
-
23andMe Launches Total Health™, its Comprehensive, Prevention-Based Health Membership
-
23andMe Announces Updated Safety and Preliminary Efficacy Data From the Phase 1/2a Study of 23ME-00610, an Investigational Antibody Targeting CD200R1
-
23andMe to offer clients personalized action plans based on genetic and other health data
-
23andMe Launches Health Action Plan to Provide Personalized Recommendations Based on Genetic and Other Health Data
-
23andMe Announces Collaboration Extension with a New Data Licensing Agreement with GSK
-
Mastercard's stock sinks toward worst day in 2 years after earnings
Trading Information
- Previous Close Price
- $0.90
- Day Range
- $0.85–0.92
- 52-Week Range
- $0.61–3.48
- Bid/Ask
- $0.86 / $0.88
- Market Cap
- $412.27 Mil
- Volume/Avg
- 237 / 3.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.47
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment include Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 816
- Website
- https://www.23andme.com
Valuation
|
Metric
|
ME
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.66 |
Price/Sales | 1.47 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ME
|
|---|---|
Quick Ratio | 2.54 |
Current Ratio | 2.93 |
Interest Coverage | — |
Quick Ratio
ME
Profitability
|
Metric
|
ME
|
|---|---|
Return on Assets (Normalized) | −21.17% |
Return on Equity (Normalized) | −27.64% |
Return on Invested Capital (Normalized) | −26.80% |
Return on Assets
ME
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Vnw | $191.5 Bil | |
DHR
| Danaher Corp | Zqsyh | $165.0 Bil | |
IQV
| IQVIA Holdings Inc | Qpyyl | $39.1 Bil | |
IDXX
| IDEXX Laboratories Inc | Nzjdbj | $38.7 Bil | |
A
| Agilent Technologies Inc | Zgt | $37.3 Bil | |
MTD
| Mettler-Toledo International Inc | Nmvkf | $23.7 Bil | |
ICLR
| Icon PLC | Ysqpd | $22.0 Bil | |
LH
| Laboratory Corp of America Holdings | Vdqhb | $18.4 Bil | |
WAT
| Waters Corp | Pkdkq | $16.6 Bil | |
ILMN
| Illumina Inc | Hwkgjj | $16.2 Bil |